Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage.
The classification of Botox includes 50U, 100U and other, and the sales proportion of 50U in 2017 is about 59.3%. Botox is used for medical and cosmetic. Medical was the largest application segment in 2017, the proportion is about 51%.

The global Botox market was valued at US$ 5828.5 million in 2019 and is expected to reach US$ 13410 million by the end of 2026, growing at a CAGR of 12.5% during 2021-2026.
This report focuses on Botox volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Botox market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Botox Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
50U
100U
Others

Segment by Application
Medical
Cosmetic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Allergan
Ipsen
Merz Pharmaceuticals
Medytox
US World Meds
LIBP